Skip to main content
Clinical Trials/IRCT20170521034070N2
IRCT20170521034070N2
Completed
Phase 3

Comparison of the efficacy of 10-day vs. 12-day concomitant therapies for first-line Helicobacter pylori eradication in Iran.

Sari University of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: Gastric ulcer. Condition 2: Duodenal ulcer.
Sponsor
Sari University of Medical Sciences
Enrollment
200
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sari University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with peptic ulcer disease according to endoscopic findings
  • Presence of Helicobacter pylori is proven in gastric tissue according to pathologic assessment of gastric biopsy
  • No history of previous treatment for Helicobacter pylori

Exclusion Criteria

  • Breast feeding
  • History of gastrointestinal surgery
  • History of gastrointestinal malignancy
  • using anticoagulant drugs
  • using anti convulsion drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials